Molecular Therapy: Nucleic Acids
Volume 1 • Issue 4
- ISSN: 2162-2531
- 5 Year impact factor: 6.7
- Impact factor: 6.5
Molecular Therapy Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic-a… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteMolecular Therapy Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic-acid-based therapeutics to treat and/or correct genetic and acquired disease. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy Nucleic Acids builds upon the success of Molecular Therapy in publishing important peer-reviewed research, cutting-edge reviews, and commentaries targeted to advances in gene- and oligonucleotide-based therapies.
Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials.
To accommodate the rapid growth of Molecular Therapy Nucleic Acids, starting in 2022, articles will be submitted and published in one of six subsections covering key topics.
Subsections include:Bioinformatics
AI
NGS
mathematical modeling
phylogenetic oligo arrays
Delivery strategies
chemistry
ligands
lipid nanoparticles
localized delivery applications
polymeric nanoparticles
systemic delivery
targeted delivery
viral vectors
Non-coding RNAs
circRNAs
lncRNAs
miRNAs
siRNAs
regulatory RNAs
Oligonucleotides: diagnostics and biosensors
aptamer-based biosensors
molecular beacons
nanostructured biosensors
radiolabeled oligonucleotides
rolling circle amplification-based biosensors
Oligonucleotides: therapies and applications
clinical studies
CMC
development
discovery
preclinical assessment
regulatory RNAs
RNA/DNA editing
ADAR
CRISPR
HDR
NHEJ
TALEN
ZFN
Visit the Cell Press website for more information about Molecular Therapy Nucleic Acids - https://www.cell.com/molecular-therapy-family/home
- ISSN: 2162-2531
- Volume 1
- Issue 4
- 5 Year impact factor: 6.7
- Impact factor: 6.5